A Phase II Trial of Poly-ICLC for Progressive, Previously Treated Low-Grade Gliomas in Children and Young Adults With Neurofibromatosis Type 1
Conditions: NF1; Low-grade Glioma Intervention: Drug: Poly ICLC Sponsors: University of Alabama at Birmingham; Children's Healthcare of Atlanta; Children's Hospital Los Angeles Not yet recruiting
Source: ClinicalTrials.gov - Category: Research Source Type: clinical trials